Antiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma

Archives of Dermatological Research

Volumn 292, Issue 5, 2000, Pages 225-232

  Leiter, Ulrike ^a   Schmid, Roland M ^a   Kaskel, Peter ^a   Peter, Ralf U ^a   Krähn, Gertraud ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Bax; Bcl 2; Bcl x; Melanoma; Melanoma metastases

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X;

ADVANCED CANCER; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOMA; METASTASIS; NEVUS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034062695     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030050479     Document Type: Article

References (36)

1. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA (1993) bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 74 : 597-608
2. Bosari S, Moneghini L, Graziani D, Lee AK, Murray JJ, Viale G (1995) bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas and adenocarcinomas. Hum Pathol 26 : 534-540
3. Cerroni L, Soyer HP, Kerl H (1995) bcl-2 protein expression in cutaneous malignant melanoma and benign melanocytic nevi. Am J Dermatopathol 17 : 7-11
4. Cheng E, Levine HY, Boise LH, Hardwick JM (1996) Bax-independent inhibition of apoptosis by bcl-xL. Nature 379 : 554-556
5. Dole M, Nunez G, Merchant AK, Maybaum J, Rode C, Bloch CA, Castle VP (1994) bcl-2 protein inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res 54 : 3253-3259
6. Friess H, Lu Z, Graber HU, Zimmermann A, Adler G, Kore M, Schmid R, Büchler M (1998) bax but not bcl-2 influences the prognosis of human pancreatic cancer. Gut 43(3) : 414-421
7. Gradilone A, Greco C, Gazzaniga P, Aglian A (1996) Bax gene expression in melanoma metastases. J Invest Dermatol 106: 382
8. Grover R, Wilson GD (1996) bcl-2 expression in malignant melanoma and its prognostic significance. Eur J Surg Oncol 22 : 347-349
9. Hellemans P (1995) Prognostic value of bcl-2 expression in invasive breast cancer. Br J Cancer 72 : 354-360
10. Jensen OM, Bolander AM (1980) Trends in malignant melanoma of the skin. World Health Stat Q 33 : 2-26
11. Kraehn G, Schartl M, Peter RU (1995) Human malignant melanoma. A genetic disease? Cancer 75 : 1228-1237
12. Krajewski S, Blomquist C, Franssila K, Krajewski M, Wasenius VM, Niskanen E (1995) Reduced expression of the pro-apoptotic gene bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res 55 : 4471-4478
13. Leek RD, Kaklamanis L, Pezzella F, Gatter KC, Harris AL (1994) Bcl-2 in human breast and carcinoma association with oestrogen receptor positive, epidermal growth factor receptor negative tumors and in situ cancer. Br J Cancer 69 : 135-139
14. McDonnell TJ (1993) Cell division versus cell death: a functional model of multistep neoplasia. Mol Carcinog 8 : 209-213
15. Minn AJ, Rudin CM, Boise LH, Thompson CB (1995) Expression of bcl-xL can confer a multidrug resistance phenotype. Blood 86 : 1903-1910
16. Miyashita T, Reed JC (1992) bcl-2 gene transfer increases relative resistance of S491 and WEHI72 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res 52 : 5407-5411
17. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9 : 1799-1805
18. Morales Ducret CR, Rijn M van de, LeBrun DP, Smoller BR (1995) bcl-2 expression in primary malignancies of the skin. Arch Dermatol 131 : 909-912
19. Ofner D, Riehemann K, Maier H, Riedmann B, Nehoda H, Schmid KW (1995) Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: correlation with tumor stage and patient survival. Oncogene 16 : 981-985
20. Ohmori T, Podack ER, Nishio K, Takahashi M, Miyahara Y, Takeda Y (1993) Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by bcl-2. Biochem Biophys Res Commun 192 : 30-36
21. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74 : 609-619
22. Oord JJ van den, Vandeghinste N, Ley M de, Wolf-Peeters C de (1994) Bcl-2 expression in human melanocytes and melanocytic tumors. Am J Pathol 145 : 294-300
23. Pezzella F, Turley H, Kuzu I, Tungekar MF, Dunnill MS, Pierce CB (1993) bcl-2 protein in non-small-cell lung carcinoma (see comments). N Engl J Med 329 : 690-694
24. Pilotti S, Collini P, Rilke F, Catoretti G, Del Bo R, Pierotti MA (1994) bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland. J Pathol 172 : 337-342
25. Reed JC (1994) Bcl-2 and the regulation of programmed cell death. J Cell Biol 124 : 1-6
26. Reed JC (1997) Double identity for proteins of the bcl-2 family. Nature 387 : 773-777
27. Rigel DH, Kopf AW, Friedman RJ (1987) The rate of malignant melanoma in the United States: are we making an impact? J Am Acad Dermatol 17 : 1050-1053
28. Saenz-Santamaria MC, Reed JA, McNutt NS, Shea CR (1994) Immunohistochemical expression of BCL-2 in melanomas and intradermal nevi. J Cutan Pathol 21 : 393-397
29. Selzer E, Schlagbauer-Wadl H, Okamoto I, Jansen B (1998) Expression of bcl-2 family members in human melanocytes, in melanoma metastases and in melanoma cell lines. Melanoma Res 8 : 197-203
30. Shimizu S, Eguchi Y, Kosaka H, Tsujimoto Y (1995) Prevention of hypoxia-induced cell death by bcl-2 and bcl-xL. Nature 374 : 811-813
31. Sumantran VN, Ealovega MW, Nunez G, Clarke MF, Wicha MS (1995) Over-expression of bcl-xS sensitizes MCF-7 cells to chemotherapy induced apoptosis. Cancer Res 55 : 2507-2510
32. Tang L, Tron V, Reed J, Trotter M (1998) Expression of apoptosis regulators in cutaneous malignant melanoma. Clin Cancer Res 4 : 1865-1871
33. Tron VA, Krajewski S, Klein-Parker H, Li G, Ho VC, Reed JC (1995) Immunohistochemical analysis of bcl-2 protein regulation in cutaneous melanoma. Am J Pathol 146 : 643-650
34. Tsujimoto Y, Cossmann J, Jaffe E, Croce C (1984) Involvement of the bcl-2 gene in human follicular lymphoma. Science 226 : 1097-1099
35. Wagener C, Bargou R, Daniel P, Bommert K, Mapara M, Dörken B (1996) Induction of the death-promoting gene bax sensitizes cultured breast-cancer cells to drug induced apoptosis. Int J Cancer 67 : 138-141
36. Williams GT, Smith CA (1993) Molecular regulation of apoptosis: genetic controls on cell death. Cell 74 : 777-779